About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
This compound exhibits a multifaceted biochemical activity profile involving receptor-level modulation, enzyme-pathway interference, and intracellular signalling adjustments. It can alter phosphorylation dynamics, metabolic flux balance, mitochondrial function, and the regulation of adaptive stress-response pathways.
Benefits and Advantages
Suitable for mechanistic pathway research, multiomics profiling, receptor-binding investigations, metabolic modelling, and experimental systems requiring controlled biochemical perturbation. Its predictable interaction patterns make it reliable for pharmacodynamic benchmarking and preclinical assay calibration.
Side Effects and Risks
Potential risks include oxidative stress imbalance, cytoskeletal disruption, unintended receptor crosstalk, dosedependent cytotoxicity, and overstimulation or suppression of regulatory pathways. with appropriate biosafety precautions.
Only GMP materials will be supplied, logistics all according to GDP.
Datasheet
| Molecular Formula | C17H17ClO6 |
|---|---|
| Molecular Weight | 352.8 g/mol |
| CAS Number | 126-07-8 |
| Storage Condition | PRECAUTIONS FOR "CARCINOGENS": Storage site should be as close as practical to lab in which carcinogens are to be used, so that only small quantities required for … expt need to be carried. Carcinogens should be kept in only one section of cupboard, an explosion-proof refrigerator or freezer (depending on chemicophysical properties …) that bears appropriate label. An inventory … should be kept, showing quantity of carcinogen & date it was acquired … Facilities for dispensing … should be contiguous to storage area. /Chemical Carcinogens/ |
| Solubility | less than 1 mg/mL at 70 °F (NTP, 1992) |
| Purity | Purity information is available upon request (COA). |
| Synonym | griseofulvin; 126-07-8; (+)-Griseofulvin; Fulvicin; Amudane |
| IUPAC/Chemical Name | (2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methylspiro[1-benzofuran-2,4'-cyclohex-2-ene]-1',3-dione |
| InChl Key | DDUHZTYCFQRHIY-RBHXEPJQSA-N |
| InChl Code | InChI=1S/C17H17ClO6/c1-8-5-9(19)6-12(23-4)17(8)16(20)13-10(21-2)7-11(22-3)14(18)15(13)24-17/h6-8H,5H2,1-4H3/t8-,17+/m1/s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
